Human VIPR2/C16DUPq36.3/DUP7q36.3 ORF/cDNA clone-Lentivirus particle (NM_003382)
Cat. No.: vGMLP000270
Pre-made Human VIPR2/C16DUPq36.3/DUP7q36.3 Lentiviral expression plasmid for VIPR2 lentivirus packaging, VIPR2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
VIPR2/C16DUPq36.3 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
---|---|---|---|
vGMLP000270 | Human VIPR2 Lentivirus particle | Pilot Grade | 1.0E+8TU |
5.0E+8TU | |||
1.0E+9TU | |||
Research Grade | 1.0E+8TU | ||
5.0E+8TU | |||
1.0E+9TU | |||
GMP-like Grade | inquiry | ||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMLP000270 |
Gene Name | VIPR2 |
Accession Number | NM_003382 |
Gene ID | 7434 |
Species | Human |
Product Type | Lentivirus particle (overexpression) |
Insert Length | 1317 bp |
Gene Alias | C16DUPq36.3,DUP7q36.3,PACAP-R-3,PACAP-R3,VIP-R-2,VPAC2,VPAC2R,VPCAP2R |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGCGGACGCTGCTGCCTCCCGCGCTGCTGACCTGCTGGCTGCTCGCCCCCGTGAACAGCATTCACCCAGAATGCCGATTTCATCTGGAAATACAGGAGGAAGAAACAAAATGTGCAGAGCTTCTGAGGTCTCAAACAGAAAAACACAAAGCCTGCAGTGGCGTCTGGGACAACATCACGTGCTGGCGGCCTGCCAATGTGGGAGAGACCGTCACGGTGCCCTGCCCAAAAGTCTTCAGCAATTTTTACAGCAAAGCAGGAAACATAAGCAAAAACTGTACGAGTGACGGATGGTCAGAGACGTTCCCAGATTTCGTCGATGCCTGTGGCTACAGCGACCCGGAGGATGAGAGCAAGATCACGTTTTATATTCTGGTGAAGGCCATTTATACACTGGGCTACAGTGTCTCTCTGATGTCTCTTGCAACAGGAAGCATAATTCTGTGCCTCTTCAGGAAGCTGCACTGCACCAGGAATTACATCCACCTGAACCTGTTCCTGTCCTTCATCCTGAGAGCCATCTCAGTGCTGGTCAAGGACGACGTTCTCTACTCCAGCTCTGGCACGTTGCACTGCCCTGACCAGCCATCCTCCTGGGTGGGCTGCAAGCTGAGCCTGGTCTTCCTGCAGTACTGCATCATGGCCAACTTCTTCTGGCTGCTGGTGGAGGGGCTCTACCTCCACACCCTCCTGGTGGCCATGCTCCCCCCTAGAAGGTGCTTCCTGGCCTACCTCCTGATCGGATGGGGCCTCCCCACCGTCTGCATCGGTGCATGGACTGCGGCCAGGCTCTACTTAGAAGACACCGGTTGCTGGGATACAAACGACCACAGTGTGCCCTGGTGGGTCATACGAATACCGATTTTAATTTCCATCATCGTCAATTTTGTCCTTTTCATTAGTATTATACGAATTTTGCTGCAGAAGTTAACATCCCCAGATGTCGGCGGCAACGACCAGTCTCAGTACAAGAGGCTGGCCAAGTCCACGCTCCTGCTTATCCCGCTGTTCGGCGTCCACTACATGGTGTTTGCCGTGTTTCCCATCAGCATCTCCTCCAAATACCAGATACTGTTTGAGCTGTGCCTCGGGTCGTTCCAGGGCCTGGTGGTGGCCGTCCTCTACTGTTTCCTGAACAGTGAGGTGCAGTGCGAGCTGAAGCGAAAATGGCGAAGCCGGTGCCCGACCCCGTCCGCGAGCCGGGATTACAGGGTCTGCGGTTCCTCCTTCTCCCGCAACGGCTCGGAGGGCGCCCTGCAGTTCCACCGCGGCTCCCGCGCCCAGTCCTTCCTGCAAACGGAGACCTCGGTCATCTAG |
ORF Protein Sequence | MRTLLPPALLTCWLLAPVNSIHPECRFHLEIQEEETKCAELLRSQTEKHKACSGVWDNITCWRPANVGETVTVPCPKVFSNFYSKAGNISKNCTSDGWSETFPDFVDACGYSDPEDESKITFYILVKAIYTLGYSVSLMSLATGSIILCLFRKLHCTRNYIHLNLFLSFILRAISVLVKDDVLYSSSGTLHCPDQPSSWVGCKLSLVFLQYCIMANFFWLLVEGLYLHTLLVAMLPPRRCFLAYLLIGWGLPTVCIGAWTAARLYLEDTGCWDTNDHSVPWWVIRIPILISIIVNFVLFISIIRILLQKLTSPDVGGNDQSQYKRLAKSTLLLIPLFGVHYMVFAVFPISISSKYQILFELCLGSFQGLVVAVLYCFLNSEVQCELKRKWRSRCPTPSASRDYRVCGSSFSRNGSEGALQFHRGSRAQSFLQTETSVI |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-T06182-Ab | Anti-VIPR2/ C16DUPq36.3/ DUP7q36.3 monoclonal antibody |
Target Antigen | GM-Tg-g-T06182-Ag | VIPR2 VLP (virus-like particle) |
ORF Viral Vector | pGMLP000270 | Human VIPR2 Lentivirus plasmid |
ORF Viral Vector | vGMLP000270 | Human VIPR2 Lentivirus particle |
Target information
Target ID | GM-T06182 |
Target Name | VIPR2 |
Gene Group Identifier (Target Gene ID in Homo species) |
7434 |
Gene ID |
100057396 (Equus caballus), 101086131 (Felis catus), 22355 (Mus musculus), 29555 (Rattus norvegicus) 611663 (Canis lupus familiaris), 706344 (Macaca mulatta), 7434 (Homo sapiens), 790124 (Bos taurus) |
Gene Symbols & Synonyms | VIPR2,Vipr2,Vip2,VPAC2,VPAC2R,VIP-R-2,VPCAP2R,PACAP-R3,DUP7q36.3,PACAP-R-3,C16DUPq36.3 |
Target Alternative Names | C16DUPq36.3,DUP7q36.3,Helodermin-preferring VIP receptor,PACAP-R-3,PACAP-R3,PACAP-R3),Pituitary adenylate cyclase-activating polypeptide type III receptor (PACAP type III receptor,VIP-R-2,VIPR2,VPAC2,VPAC2 receptor (VPAC2R),VPAC2R,VPCAP2R,Vasoactive intestinal polypeptide receptor 2,Vip2,Vipr2 |
Uniprot Accession |
P35000,P41587,P41588
Additional SwissProt Accessions: P41588,P35000,P41587 |
Uniprot Entry Name | |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target |
Disease | cancer |
Disease from KEGG | cAMP signaling pathway, Neuroactive ligand-receptor interaction |
Gene Ensembl | ENSECAG00000007939, ENSMUSG00000011171, ENSCAFG00845015325, ENSMMUG00000009611, ENSG00000106018, ENSBTAG00000037649 |
Target Classification | GPCR |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.